Welcome back, everyone. We hope your weekend was relaxing and you had time to do something special. Now, though, the routine returns and this means gearing up for those meetings and deadlines. Please join us then as we brew the mandatory cup of stimulation to get started. And of course, there is the news of the world to rummage through. Good luck, today, and stay in touch...
Watson May Bid For Sigma Pharmaceuticals (The Age)
A Growing Use Of Direct To Pharmacy Distribution (PharmTech)
Pills Under Way To Treat Non-Food Allergies (Los Angeles Times)
Sanofi May Have To Raise Price For Genzyme (Bloomberg News)
Novo, Lilly And Novartis May Bid For Ascendis (Bloomberg News)